Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.28 - $1.16 $338,010 - $1.4 Million
-1,207,179 Reduced 15.3%
6,685,393 $2.21 Million
Q1 2024

May 08, 2024

BUY
$1.06 - $1.67 $245,145 - $386,219
231,269 Added 3.02%
7,892,572 $9.16 Million
Q4 2023

Feb 06, 2024

BUY
$1.26 - $1.79 $306,061 - $434,801
242,906 Added 3.27%
7,661,303 $12.9 Million
Q3 2023

Nov 08, 2023

BUY
$1.61 - $2.54 $2.5 Million - $3.95 Million
1,554,080 Added 26.5%
7,418,397 $13.4 Million
Q2 2023

Aug 09, 2023

BUY
$1.14 - $1.95 $586,526 - $1 Million
514,497 Added 9.62%
5,864,317 $10.9 Million
Q1 2023

May 11, 2023

BUY
$1.2 - $2.19 $750,582 - $1.37 Million
625,485 Added 13.24%
5,349,820 $7.12 Million
Q4 2022

Feb 13, 2023

BUY
$1.63 - $3.52 $1.18 Million - $2.55 Million
723,610 Added 18.09%
4,724,335 $7.98 Million
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $1.02 Million - $5.21 Million
1,394,051 Added 53.48%
4,000,725 $12.5 Million
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $863,440 - $1.65 Million
-392,473 Reduced 13.09%
2,606,674 $6.2 Million
Q1 2022

May 13, 2022

BUY
$2.83 - $8.69 $80,507 - $247,213
28,448 Added 0.96%
2,999,147 $12.1 Million
Q4 2021

Feb 11, 2022

BUY
$8.31 - $14.92 $24.7 Million - $44.3 Million
2,970,699 New
2,970,699 $24.7 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.